{"id":1262,"date":"2023-11-09T07:00:00","date_gmt":"2023-11-09T07:00:00","guid":{"rendered":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/"},"modified":"2024-08-06T12:24:17","modified_gmt":"2024-08-06T12:24:17","slug":"acarix-ab-publ-publicerar-delarsrapport-juli-september-2023","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/","title":{"rendered":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Fortsatt momentum i USA och st\u00e4rkt finansiering p\u00e5 plats<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Vi \u00e4r n\u00f6jda med int\u00e4ktstillv\u00e4xten i USA under Q3, d\u00e4r vi g\u00f6r betydande investeringar f\u00f6r att \u00f6ka f\u00f6rs\u00e4ljningen via v\u00e5r kostnadseffektiva hybridf\u00f6rs\u00e4ljningsmodell. I syfte att ytterligare \u00f6ka tillv\u00e4xttakten i USA planeras f\u00f6r\u00e4ndringar i f\u00f6rs\u00e4ljningsorganisationen. Vi fokuserar f\u00f6r n\u00e4rvarande p\u00e5 de tv\u00e5 Veterans Affairs (VA)-systemen i delstaten Louisiana, som redan k\u00f6pt CADScor-system, medan n\u00e5gra andra VA:s s\u00f6ker godk\u00e4nnanden och medel f\u00f6r CADScor-anv\u00e4ndning. Vi g\u00f6r ocks\u00e5 p\u00e5tagliga framsteg med ett specifikt, stort integrerat sjukhussystem (IDN) samtidigt som vi forts\u00e4tter att g\u00f6ra framsteg med att utveckla ytterligare aff\u00e4rsm\u00f6jligheter.<\/p>\n<p><em>Utdrag ur tf. VD Fred Colens kommentar till del\u00e5rsrapporten.<\/em><\/p>\n<p><strong>Tredje kvartalet 2023 j\u00e4mf\u00f6rt med samma period 2022<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Int\u00e4kterna under tredje kvartalet uppgick till 1 573 kSEK (1 164). Bruttoresultatet uppgick till 1 292 kSEK (921) vilket motsvarar en bruttomarginal om 82 % (79 %) och en f\u00f6rb\u00e4ttring med 3 procentenheter j\u00e4mf\u00f6rt med samma period 2022.<\/li>\n<li>Under kvartalet s\u00e5ldes 14 (14) CADScor\u00aeSystem och 1 903 (1 812) patcher.<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 18 517 kSEK (21 653).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till -17 291 kSEK (-21 106).<\/li>\n<li>Periodens nettokassafl\u00f6de uppgick till -16 705 kSEK (-21 218).<\/li>\n<li>Resultat per aktie uppgick till -0,04 SEK (-0,08).<\/li>\n<\/ul>\n<p><strong>F\u00f6rsta nio m\u00e5naderna 2023 j\u00e4mf\u00f6rt med samma period 2022<\/strong><\/p>\n<ul>\n<li>Int\u00e4kterna under f\u00f6rsta nio m\u00e5naderna uppgick till 5 067 kSEK (4 169). Bruttoresultatet uppgick till 4 270 kSEK (3 292) vilket motsvarar en bruttomarginal om 84 % (79 %) och en f\u00f6rb\u00e4ttring med 5 % enheter j\u00e4mf\u00f6rt med samma period 2022.<\/li>\n<li>Under perioden s\u00e5ldes 36 (48) CADScor\u00aeSystem och 7 120 (6 252) patcher.<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 59 825 kSEK (57 153).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till -55 775 kSEK (-54 372).<\/li>\n<li>Nettokassafl\u00f6det uppgick till -2 453 kSEK (12 372).<\/li>\n<li>Likvida medel uppgick till 9 246 kSEK (29 409).<\/li>\n<li>Resultat per aktie uppgick till -0,13 SEK (-0,22). Inga utsp\u00e4dningseffekter uppkom.<\/li>\n<li>Antal aktier per balansdagen uppg\u00e5r till 452 868 010 (251 972\u00a0194).<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser under tredje kvartalet 2023<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Den 28 augusti meddelade bolaget utn\u00e4mningen av Dr. Deepak R. Talreja, MD, som ny medicinsk r\u00e5dgivare. Med en imponerande bakgrund inom kardiologi tillf\u00f6r Dr. Talreja bred kunskap och expertis till Acarix, vilket ytterligare st\u00e4rker bolagets engagemang f\u00f6r att transformera tidig hj\u00e4rtdiagnostik med hj\u00e4lp av banbrytande akustisk och AI-baserad teknologi.<\/li>\n<li>Den 29 augusti meddelade bolaget betydande framsteg i anv\u00e4ndningen av CADScor System inom Veterans Administration (VA), den st\u00f6rsta v\u00e5rdgivaren i USA. VA Healthcare System i syd\u00f6stra Louisiana har nu godk\u00e4nt inkluderingen av CADScor System i dess Standard Operating Procedure (SOP) f\u00f6r riskstratifiering av symtomatiska patienter med misst\u00e4nkt kransk\u00e4rlssjukdom (CAD). Vidare har ytterligare ett VA sjukhus &#8211; Biloxi VA Medical Center (VA Gulf Coast Veterans Healthcare System) lagt f\u00f6rsta order p\u00e5 CADScor System med tillh\u00f6rande patcher.<\/li>\n<li>Den 4 september meddelade bolaget samarbetet med Maeva Health, under ledning av Dr. Peter Svalander, VD, f\u00f6r lansering av CADScor-systemet p\u00e5 Mauritius och vidare ut p\u00e5 den expansiva \u00f6stafrikanska marknaden med en befolkning p\u00e5 \u00f6ver 485 miljoner. Partnerskapet med Maeva resulterade i en f\u00f6rsta order p\u00e5 tre CADScor System.<\/li>\n<li>Den 11 september meddelade bolaget om beslut g\u00e4llande f\u00f6retr\u00e4desemission om ca 54 MSEK, fullt garanterat av bland annat en dansk life science fond.<\/li>\n<li>Den 27 september meddelade bolaget om den f\u00f6rsta aff\u00e4ren inom osteopatisk medicin p\u00e5 USA-marknaden. Den initiala ordern av CADScor\u00aeSystem fr\u00e5n Legacy Medical LLC, bel\u00e4gen i delstaten Georgia, \u00e4r ytterligare en viktig milstolpe i bolagets p\u00e5g\u00e5ende kommersialiseringsarbete p\u00e5 den amerikanska marknaden.<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser efter den 30 september 2023<\/strong><strong><br \/><\/strong><\/p>\n<ul>\n<li>Den 10 oktober meddelade bolaget att VD Helen Ljungdahl Round sjukskrivits f\u00f6r behandling av cancer under en f\u00f6rv\u00e4ntad period om cirka sex m\u00e5nader. Styrelsen har med omedelbar verkan utsett Fred Colen till tillf\u00f6rordnad VD under Helens sjukskrivning.<\/li>\n<li>Den 20 oktober meddelade bolaget det slutliga utfallet i nyemissionen av units, best\u00e5ende av aktier och teckningsoptioner av serie 2024:U1 (TO2) och serie 2024:U2 (TO3), med f\u00f6retr\u00e4desr\u00e4tt f\u00f6r befintliga aktie\u00e4gare (\u201dF\u00f6retr\u00e4desemissionen\u201d) som avslutades den 18 oktober 2023. Totalt 67 126 093 units, motsvarande cirka 74,1 procent av F\u00f6retr\u00e4desemissionen, tecknades med och utan st\u00f6d av unitr\u00e4tter. D\u00e4rmed tilldelas de garanter som l\u00e4mnat toppgarantier totalt 23 447 509 units, motsvarande cirka 25,9 procent av F\u00f6retr\u00e4desemissionen. Acarix tillf\u00f6rs genom F\u00f6retr\u00e4desemissionen sammanlagt cirka 54,3 MSEK f\u00f6re avdrag av kostnader h\u00e4nf\u00f6rliga till F\u00f6retr\u00e4desemissionen.<\/li>\n<\/ul>\n<p>L\u00e4nk till rapporten: <a href=\"https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar\" rel=\"noopener\" target=\"_blank\">https:\/\/www.acarix.com\/for-investors\/financial-reports-and-calendar<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-5f6793025012\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information, kontakta:<\/strong><br \/>Fred Colen, tf. VD, email <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ja928lyd5LVtH4Zqz3RIoAP_vZ4DwD4jGGSS8irkeyApUfYtjFhf7OEe4gNScgnB2UBNq2dY0DN26ofiUpN4WG_gdBET6JivdcXqFArn7NQ=\" rel=\"noopener\" target=\"_blank\">fred.colen@acarix.com<\/a>\u00a0<br \/>Christian Lindholm, CFO, tel +46\u00a0705 118333, email <a href=\"mailto:christian.lindholm@acarix.com\" rel=\"noopener\" target=\"_blank\">christian.lindholm@acarix.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-ddf9d1ef3849\">\n<p><strong class=\"mfn-heading-1\">Om Acarix<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">Acarix \u00e4r ett svenskt medicintekniskt bolag som utvecklar innovativa l\u00f6sningar f\u00f6r snabb AI-baserad uteslutning av kransk\u00e4rlssjukdom (CAD). Det CE-m\u00e4rkta CADScor\u00ae System, som \u00e4ven har f\u00e5tt DeNovo-godk\u00e4nnande fr\u00e5n FDA, \u00e4r avsett f\u00f6r patienter som upplever br\u00f6stsm\u00e4rta med misst\u00e4nkt kransk\u00e4rlssjukdom, och har utformats f\u00f6r att bidra till att minska miljontals fall av on\u00f6dig, invasiv och kostsam diagnostik. CADScor System anv\u00e4nder avancerad akustik och AI-teknik f\u00f6r att p\u00e5 ett icke-invasivt s\u00e4tt utesluta CAD p\u00e5 mindre \u00e4n 10 minuter, med minst 96 % s\u00e4kerhet. CADScor-systemet har anv\u00e4nts p\u00e5 mer \u00e4n 29 000 patienter och rekommenderas som ett f\u00f6rstahands diagnostiskt hj\u00e4lpmedel enligt beskrivningen i det kliniska arbetsfl\u00f6det som utvecklats i samarbete med American College of Cardiology (ACC). Acarix \u00e4r noterat p\u00e5 Nasdaq First North Premier Growth Market (ticker: ACARIX). Erik Penser Bank AB (+46 8 463 83 00, <a href=\"mailto:certifiedadviser@redeye.se\" rel=\"noopener\" target=\"_blank\">certifiedadviser@penser.se<\/a>) \u00e4r bolagets Certified Adviser. F\u00f6r mer information bes\u00f6k <a href=\"http:\/\/www.acarix.com.\" rel=\"noopener\" target=\"_blank\">www.acarix.com<\/a>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><br \/><a class=\"mfn-primary\" href=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/acarix-q3-2023-swe-final.pdf\" rel=\"noopener\" target=\"_blank\">Acarix Q3 2023 Swe Final<\/a><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Fortsatt momentum i USA och st\u00e4rkt finansiering p\u00e5 plats Vi \u00e4r n\u00f6jda med int\u00e4ktstillv\u00e4xten i USA under Q3, d\u00e4r vi<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[62,67,70,71,77],"class_list":["post-1262","post","type-post","status-publish","format-standard","hentry","category-press","tag-regulatory","tag-regulatorylisting","tag-subreport","tag-subreportinterim","tag-subreportinterimq3"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix\" \/>\n<meta property=\"og:description\" content=\"Fortsatt momentum i USA och st\u00e4rkt finansiering p\u00e5 plats Vi \u00e4r n\u00f6jda med int\u00e4ktstillv\u00e4xten i USA under Q3, d\u00e4r vi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-06T12:24:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023\",\"datePublished\":\"2023-11-09T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:24:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/\"},\"wordCount\":929,\"keywords\":[\":regulatory\",\":regulatory:listing\",\"sub:report\",\"sub:report:interim\",\"sub:report:interim:q3\"],\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/\",\"name\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2023-11-09T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:24:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","og_description":"Fortsatt momentum i USA och st\u00e4rkt finansiering p\u00e5 plats Vi \u00e4r n\u00f6jda med int\u00e4ktstillv\u00e4xten i USA under Q3, d\u00e4r vi","og_url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/","og_site_name":"Acarix","article_published_time":"2023-11-09T07:00:00+00:00","article_modified_time":"2024-08-06T12:24:17+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023","datePublished":"2023-11-09T07:00:00+00:00","dateModified":"2024-08-06T12:24:17+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/"},"wordCount":929,"keywords":[":regulatory",":regulatory:listing","sub:report","sub:report:interim","sub:report:interim:q3"],"articleSection":["Press"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/","url":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/","name":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli - september 2023 - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2023-11-09T07:00:00+00:00","dateModified":"2024-08-06T12:24:17+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/acarix-ab-publ-publicerar-delarsrapport-juli-september-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"Acarix AB (publ) publicerar del\u00e5rsrapport, juli &#8211; september 2023"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=1262"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1262\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=1262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=1262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=1262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}